Clinical Trial Update: Comparative Efficacy Study of 10 mg Dequalinium Chloride (Fluomizin) in the Treatment of Vulvovaginal Candidiasis [Phase 4]

View source ↗

Summary

Phase 4 comparative efficacy trial of 10 mg dequalinium chloride (Fluomizin) for vulvovaginal candidiasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvovaginal Candidiasis

Drugs mentioned

• Fluomizin (dequalinium chloride)

Snippet

Sponsor: Medinova AG | Conditions: Vulvovaginal Candidiasis | Phase 4 | Status: COMPLETED